We have demonstrated that sodium pentobarbital inhibited the activatio
n of the human red blood cell plasma membrane Ca2+-ATPase produced by
dimerization of enzyme monomers or by calmodulin binding to enzyme mon
omers. The effects of the barbiturate were dose-dependent. Both V-max
and Ca2+ affinity were reduced. The Ca2+-ATPase activity of the dimeri
c enzyme was distinctly less sensitive with respect to the effective i
nhibitory concentrations of pentobarbital and to the rate of onset of
inhibition than was the calmodulin-dependent activation of enzyme mono
mers. Temperature dependence of the inhibition was in agreement with d
irect, nonpolar interactions of pentobarbital with a water-exposed non
polar patch on the surface of this transmembrane protein. The barbitur
ate prevented the increase of intrinsic tryptophan fluorescence associ
ated with substrate Ca2+ binding to the enzyme dimer, On the basis of
the barbiturate effects we propose a model for the action of detergent
-like compounds on the enzyme, They inhibit Ca2+-ATPase activity by bi
nding to a nonpolar patch on the water-exposed dimerization surface of
the enzyme monomer, part of which is also the binding site for calmod
ulin. The model assumes that their binding to the nonpolar patch on th
e monomer interferes with dimerization and weakens but does not prohib
it calmodulin binding, whose activation of the enzyme is then submaxim
al. The model should be applicable to other proteins as the two activa
tion pathways studied have been demonstrated for various enzymes.